ASTRAZENECA PHARMACEUTICALS: Drug Recall
Recall #D-0028-2026 · 10/08/2025
Class II: Risk
Recall Details
- Recall Number
- D-0028-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- ASTRAZENECA PHARMACEUTICALS
- Status
- Ongoing
- Date Initiated
- 10/08/2025
- Location
- Gaithersburg, MD, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 916 pre-filled syringes
Reason for Recall
Lack of Assurance of Sterility:
Product Description
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Distribution Pattern
Nationwide in the U.S
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.